Docoh
Loading...

RGBP Regen BioPharma

Press releases

From Benzinga Pro
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Regen BioPharma, Inc. - RGBP
19 Jan 22
Press Releases
New York, New York--(Newsfile Corp. - January 19, 2022) - Pomerantz LLP is investigating claims on behalf of investors of Regen BioPharma, Inc. ("Regen" or the "Company") (OTC:RGBP). Such investors are advised to
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Regen BioPharma, Inc. - RGBP
17 Jan 22
Small Cap, Press Releases
NEW YORK, Jan. 17, 2022 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Regen BioPharma, Inc. ("Regen" or the "Company") (OTCMKTS: RGBP). Such investors are advised to
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Regen BioPharma, Inc. - RGBP
11 Jan 22
Press Releases
New York, New York--(Newsfile Corp. - January 11, 2022) - Pomerantz LLP is investigating claims on behalf of investors of Regen BioPharma, Inc. ("Regen" or the "Company") (OTC:RGBP). Such investors are advised to
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Regen BioPharma, Inc. - RGBP
6 Jan 22
Small Cap, Press Releases
NEW YORK, Jan. 6, 2022 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Regen BioPharma, Inc. ("Regen" or the "Company") (OTCMKTS: RGBP). Such investors are advised to
REGEN BIOPHARMA, INC.: MESSAGE TO THE SHAREHOLDERS FROM THE CHAIRMAN AND CHIEF EXECUTIVE OFFICER
30 Dec 21
Small Cap, Press Releases
SAN DIEGO, Dec. 30, 2021 /PRNewswire/ -- Regen BioPharma, Inc. (OTC:RGBP) and (OTC:RGBPP): First of all I would like to wish all our shareholders a happy holiday season. It has been a long year with many challenges
Regen BioPharma, Inc. Announces Signing of a Letter of Intent to Acquire an In vitro Diagnostics Start-Up Company Canary Oncoceutics, Inc. Which is Developing Functional Cancer Tests for Personalized Medicine
17 Nov 21
Small Cap, Press Releases
SAN DIEGO, Nov. 17, 2021 /PRNewswire/ -- Regen BioPharma, Inc. (OTC:RGBP) and (OTC:RGBPP) is currently completing a strategic analysis of its next 5 years of growth. As part of this analysis, diversifying beyond